ASSESSMENT OF THE USE OF THE VEMONIS FEMI® MEDICINAL PRODUCT IN THE TREATMENT OF DYSMENORRHEA IN EVERYDAY CLINICAL PRACTICE (ADM/VEM/2020)

Study type

• Study type:
  Non-interventional study
• Scope of the study:
  Drug utilisation

Population studied

• Age groups:
  Adults (18 to < 46 years)

  Adults (46 to < 65 years)
• Estimated number of subjects:
  350

Study design details

• Main study objective:
  Main aim of the Study: Assessment of the use of VEMONIS FEMI® in the treatment of dysmenorrhea in everyday clinical practice in the population of Polish women using this preparation. Additional aim of the Study: The assessment of the treatment efficacy and tolerance.
• Outcomes:
  Assessment of the use of VEMONIS FEMI® in the treatment of dysmenorrhea in everyday clinical practice in the population of Polish women using this preparation, The assessment of the treatment efficacy and tolerance.
• Data analysis plan:
  20 gynaecologists and doctors currently in the process of obtaining the gynaecology specialization as well as 15 general practitioners, who utilize the VEMONIS FEMI® medicinal product the treatment of dysmenorrhea in their everyday clinical practice, will participate in the Study. Data on the use of VEMONIS FEMI® as well as the characteristics of the Patients in whom it was used as well as its tolerance and efficacy will be noted in the Study Questionnaires (SQ) during 3 consecutive, routine visits in three consecutive menstrual cycles.